Sentence examples for pharmacovigilance data from inspiring English sources

Safety data from comparative RCTs, non-comparative RCTs (e.g. post-marketing pharmacovigilance data) and regulatory summaries are considered in the relative effectiveness assessment (Section 5.9 SMSE STA).

There have been no such studies in resource-limited settings where risk is arguably increased as a result of less laboratory monitoring, high rates of background illness (which may result in adverse effects being missed), lack of affordable alternative treatments, use of fixed dose combinations (that offer less flexibility for managing interactions) and lack of pharmacovigilance data.

Promote better and broader use of existing pharmacovigilance data for patient safety.

Specifically, from pharmacovigilance data multivariate logistic regression identified 18 drugs associated with IMDILI (P < 0.00015).

Early estimation procedures tailored to available pharmacovigilance data, i.e. spontaneous reporting data, should be sought.

Recent pharmacovigilance data of the FDA show 212 co-occurrences of pravastatin therapy and myopathy, however.

Marietta Rottenkolber for the analysis of the network of regional pharmacovigilance centers data in the IBE.

Novartis should publish all their own first-hand extensive epidemiological and pharmacovigilance updated data on morbidity, mortality and treatment outcomes of deferasirox, which are necessary and essential information required by doctors and patients.

We are indebted to Petra Birkner, Veronika Brill, Anne Ehrlich, Olivia Endress, Peter Friedrich-Mai, Jana Heuer, Petra Krensel, Kai Kronfeld, Rolf Meinert, Kornelia Pfeiffer, Christina Reck, Christian Ruckes, Daniel Wachtlin and Sabine Wolf, Interdisciplinary Centre of Clinical Studies (IZKS) Mainz for clinical monitoring, pharmacovigilance, regulatory affairs, data management and biometry.

In this pharmacovigilance study using data from 127 504 individuals with MDD in a single large healthcare system, we identified a significantly elevated risk for GI haemorrhage and stroke when high-serotonin transporter affinity antidepressants were prescribed compared with low-serotonin transporter affinity antidepressants.

Co-use of a nicotine patch with cigarettes was a safety concern, but in the absence of evidence based data, pharmacovigilance alert, and lack of disposition for it in the marketing licences for NRT, the women were permitted to stay in the study despite a relapse.